by Thomas R. Kreil
Emerg Infect Dis. Vol. 21, Nr. 3; March 2015
Read online at: http://wwwnc.cdc.gov/eid/article/21/3/14-1838_article
Clinical evidence suggests that antibodies from reconvalescent donors (persons who have recovered from infection) may be effective in the treatment of Ebola virus infection. Administration of this treatment to Ebola virus-infected patients while preventing the transmission of other pathogenic viruses may be best accomplished by use of virus-inactivated reconvalescent plasma.